Patient Monitoring & Vital Signs

Germaine Laboratories, Inc. is an FDA-registered manufacturer and distributor of in vitro diagnostic tests and reagents serving medical, drug testing, veterinary, and food & beverage industries since 1990. The company holds ISO 13485:2016 certification for quality management systems applicable to diagnostic test manufacturing. Product portfolio includes urinalysis reagent strips (AimStrip®), hemoglobin testing systems (AimStrip® Hemoglobin), strep detection tests (StrepAim®), pregnancy tests (AimStep®), blood glucose monitoring systems (VQPet H for veterinary use), COVID-19 antigen home tests (Flowflex™), and reducing substance tablets for food testing (AimTab™). The company serves physician offices, walk-in clinics, pharmacies, hospitals, drug court programs, schools, workplaces, veterinary practices, and food & beverage manufacturers. All products are CLIA-waived where applicable and FDA-approved. Germaine Laboratories operates as both a manufacturer and distributor, offering bulk packaging, private labeling, OEM arrangements, and exclusive distributorship opportunities. The company provides laboratory services and tableting contract manufacturing capabilities. Customer service and technical support are available 24/7 via phone and email, with emphasis on rapid response and order fulfillment.

Therakos LLC manufactures the THERAKOS® CELLEX® Photopheresis System, an FDA-approved extracorporeal photopheresis (ECP) device for the palliative treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) unresponsive to other therapies. The system performs ultraviolet-A (UVA) irradiation of leukocyte-enriched blood in the presence of 8-methoxypsoralen (8-MOP), with co-administered pharmaceutical UVADEX® (methoxsalen) sterile solution. The company provides a complete therapeutic platform including the photopheresis system hardware, consumables, operator training through the Therakos Institute, and comprehensive customer support services branded as Therakos Total Care. The system is designed for use in clinical settings where standard medical emergency equipment and volume management capability are available. Following acquisition by CVC, certain operations continue under transition services agreement with Mallinckrodt Pharmaceuticals. Therakos markets primarily to hematology-oncology centers, dermatology departments, and specialized treatment centers managing CTCL patients. The company maintains dedicated business manager support and professional education programs for treating physicians and clinical staff. Product indications and contraindications are clearly defined with specific patient selection criteria and comprehensive safety protocols documented in the operator's manual and UVADEX prescribing information.

Corvascular Diagnostics, LLC manufactures the VasoGuard® Peripheral Vascular Testing System, a comprehensive family of diagnostic devices for non-invasive vascular assessment. The product line includes five modular configurations (V2, V4, V6, V8, V10) designed to support varying clinical testing protocols, from basic screening to advanced multi-parameter diagnostics. Each system integrates pressure channel monitoring (2–10 channels), photoplethysmography (PPG) probes (2–5 units), and Doppler ultrasound capabilities (8 MHz and/or 4 MHz), coupled with medical-grade touchscreen interfaces and height-adjustable carts. All units are manufactured in the USA with on-site support and service. The company provides a 5-year bumper-to-bumper warranty and optional accidental damage coverage (ADC), with on-site training included as standard. The VasoGuard line serves peripheral vascular diagnostic needs in hospital systems, vascular labs, and outpatient clinics. Hardware upgradability between models allows clinical facilities to expand testing capacity. The company emphasizes clinical accuracy, state-of-the-art pressure monitoring, and Doppler envelope technology for reliable patient assessment.

Belun Technology designs and manufactures medical-grade wearable devices and AI-powered software platforms for sleep health monitoring, home sleep apnea testing, and remote patient vital signs monitoring. The company's core offerings include the Belun® Ring, an FDA 510(k)-cleared wearable device that performs home sleep apnea screening and monitors sleep health using clinically validated algorithms, and the Belun® remoVital system, a real-time remote vital signs monitoring solution comprising the Belun® Ring, Belun® COR (body temperature sensor), and a communication hub. The remoVital system measures blood oxygen saturation, pulse rate, and body temperature, with alert functionality designed to enable early detection of clinical deterioration and support timely medical intervention. Products target both consumers seeking self-managed wellness monitoring and healthcare professionals requiring scalable remote monitoring solutions for clinical accuracy and care quality improvement. The company emphasizes medical-grade accuracy, ease of use, and affordability. Belun holds FDA 510(k) clearance for its sleep monitoring and vital signs monitoring systems. The platform employs proprietary AI algorithms for predictive analytics and personalized care delivery. Markets served include home-based sleep apnea screening, remote patient monitoring in residential care facilities, and integrated telehealth/remote care workflows. The company has received strategic investment from IHH Healthcare and Gravity Capital Partners, indicating growth in global expansion and product development.

Acro Biotech, Inc. is a medical diagnostics manufacturer based in Montclair, California, specializing in point-of-care and clinical laboratory testing solutions. The company develops and distributes a diverse portfolio of diagnostic analyzers and rapid testing systems across multiple therapeutic and clinical domains. Product lines include respiratory infection rapid tests (COVID-19 and other respiratory panels, though COVID tests are not FDA-cleared for US distribution), drugs of abuse screening tests, cardiac biomarker assays, urine analyzers, fluorescence immunoassay analyzers, and multiparameter handheld meters for hemoglobin, cholesterol, uric acid, and glucose testing. The company also offers solutions for women's health, infectious disease serology, tumor markers, and veterinary diagnostics. Key analyzer platforms include the ATR-ACO300 urine analyzer, AFR-600 fluorescence immunoassay system (Apoti), AHR-100 multiparameter meter for hemoglobin/cholesterol/uric acid/glucose, and LF Reader systems. The company serves clinical laboratories, point-of-care testing facilities, and veterinary markets with rapid testing and automated laboratory equipment. No specific FDA 510(k) clearances, ISO certifications, or CE Mark designations are stated on the website. Manufacturing capabilities and regulatory status for products marketed outside the US are not detailed in available content.

International Health Technologies (IHT) is a biotechnology company specializing in non-invasive health assessment instruments. The company manufactures the BioScan system, a cutting-edge, real-time biomarker analysis platform that delivers advanced health insights without blood tests or invasive procedures. BioScan uses advanced biofeedback technology to provide personalized wellness reports and early health issue detection. The product line includes the BioScan MSA System, BioScan MSA-Ivory System, BioScan SRT System, and BioScan SRT-Fit System, each configured for different clinical and professional settings. Software offerings include MSA 149U and SRT 116G platforms. IHT serves healthcare practitioners, wellness professionals, and individuals globally and has been operating for over 30 years. The company provides comprehensive support including technical assistance, remote support, training webinars, and a knowledge base. Business operations span North America and Europe, with headquarters in Salt Lake City, Utah. IHT offers equipment financing through partnerships and maintains an active schedule of webinars and practitioner training events.

Isla Lab Products, LLC is a Puerto Rico–based medical laboratory distributor and supplier founded in 1977 and expanded to the Caribbean in 2007. Headquartered at Amelia Industrial Park in Guaynabo, PR, the company operates a 30,000-square-foot facility with sales, customer service, technical and professional support, cold chain distribution, conference facilities, and a training center. The company distributes and supplies a comprehensive portfolio of clinical laboratory analyzers, reagents, consumables, and diagnostics across multiple specialties: clinical chemistry, immunochemistry, microbiology, hematology, transfusion medicine and blood banking, point-of-care testing, molecular diagnostics, pathology, toxicology, coagulation studies, COVID-19 testing, and rapid diagnostics. Key product offerings include automated chemistry analyzers (cobas® c 513, cobas® pure), microbiology identification and blood culture systems (VITEK® 2, BACT/ALERT® VIRTUO®, BACT/ALERT® 3D), rapid antigen testing platforms (Quidel Sofia 2), blood collection tubes (Vacuette®), and hematology analyzers (BC-5390). The company serves clinical laboratories, hospitals, diagnostic centers, and healthcare institutions across Puerto Rico and the Caribbean islands. Isla Lab Products maintains technical service capabilities, professional training, and cold chain logistics to support customer operations. The company operates as an authorized distributor for major in vitro diagnostics manufacturers and provides B2B procurement solutions for laboratory testing infrastructure and consumables.

seca is a global manufacturer of medical measurement and body composition analysis systems for healthcare, wellness, and fitness markets. The company designs and distributes precision scales, height measurement devices, and bioimpedance analysis (BIA) systems for patient measurement and monitoring in clinical, hospital, and home settings. Product lines include the seca 777 series (modular measuring stations), seca XLine (advanced patient measurement platform), seca mBCA series (medical body composition analyzers including mBCA Alpha, mBCA Ultra, mBCA Go, and mBCA variants 514 and 525), and the seca TRU Alpha (fitness and medical body composition system). The company also offers the seca 284 and 286 EMR-ready measuring stations with integrated digital height rods and optional wireless transmission. seca manufactures mechanical and digital scales (models 700, 755), mobile measuring mats (seca 210), and baby scales (seca 334, seca 374) for pediatric and neonatal applications. Devices support cloud-based data management and EMR integration. seca holds MDR (Medical Device Regulation) certification since 2020, indicating compliance with EU medical device standards. The company serves hospitals, clinics, physician offices, wellness centers, and fitness facilities. Manufacturing capabilities include digital connectivity, voice guidance systems, and rechargeable battery options for portable configurations.

Millar LLC is a medical sensor technology company specializing in MEMS (microelectromechanical systems) pressure sensors and related sensing solutions for medical devices and industrial applications. Founded in 1969, Millar has over 55 years of expertise in high-fidelity pressure measurement for acute and chronic monitoring. The company's core product portfolio includes acute pressure sensors (minimally invasive, high-accuracy measurement), chronic pressure sensors (TiSense implantable technology for up to 10-year monitoring in titanium housings), ISFET pH sensors, electrical conductivity (EC) sensors, oxidation-reduction potential (ORP) sensors, temperature sensors, and volume measurement solutions. Millar operates as a Contract Design and Manufacturer (CDMO) providing end-to-end sensor integration services from discovery and proof of concept through prototyping, manufacturing development, design validation, clinical trials, and device commercialization. The company holds ISO 13485 certification and operates an ISO Class 7 clean room facility supporting FDA-approved medical device production. Millar also operates a pure-play MEMS microfoundry for custom sensor fabrication. Primary markets include cardiovascular monitoring, hemodynamic pressure measurement, and OEM medical device integration. The company serves both medical device manufacturers requiring sensor integration and industrial customers requiring environmental and process monitoring solutions. Regulatory credentials include experience with FDA 510(k) pathways and clinical trial support.

Integrity Medical Products is a B2B supplier of medical equipment accessories, replacements, and consumables for healthcare facilities. The company specializes in patient monitoring cables and sensors (SpO2, ECG, invasive/non-invasive blood pressure) compatible with major monitor brands, available at 30–60% savings versus OEM pricing, with one-year warranties. Product portfolio includes monitor mounting arms and cable management systems (five-year warranty), nurse call accessories with pillow speakers (two-year warranty), medical carts and stands for monitors, ventilators, and suction pumps, and hospital furniture including overbed tables, bedside cabinets, fetal monitoring carts, bassinets, stools, and chairs with antimicrobial construction. Integrity also supplies suction and oxygen therapy products (analog and digital suction regulators, portable suction pumps, flowmeters, gas regulators, cylinder carts, high-pressure hoses) and offers patent-pending Integrated Flowmeter technology. Additional product lines include diagnostic systems (ophthalmoscopes/otoscopes with Welch Allyn compatibility), endoscopy/OR monitors and video accessories (wireless transmitters, fiber optic light cords, custom screen protectors), operating room table and stretcher pads (gel, foam, and self-adjusting air options for pressure ulcer prevention), and bed and stretcher accessories with custom fabrication available. The company targets hospitals, surgical centers, and critical care facilities, emphasizing affordability, compatibility with existing infrastructure, and practical solutions to institutional procurement challenges.

BeamMed Inc. is a US-based manufacturer and distributor of portable bone density scanning equipment for clinical and preventive care settings. The company specializes in quantitative ultrasound (QUS) bone densitometry, primarily through its flagship Sunlight MiniOmni product line—ultra-portable, handheld bone sonometers that weigh less than 2 lbs and deliver results in under one minute. The MiniOmni is designed for non-invasive, radiation-free bone mineral density assessment and is positioned to address HEDIS OMW (Osteoporosis Management in Women) quality measures and OMW-with-fracture gaps in Medicare Advantage and commercial health plans. The device supports USB connectivity to PC/laptop for reporting and EMR integration. BeamMed markets rental and purchase options to primary care practices, community health screening organizations, nursing homes, urgent care centers, and Medicare Advantage insurers. The company serves a broad range of high-profile health systems and payers (Kaiser Permanente, UnitedHealthcare, Humana, Optum, Blue Cross, Geisinger, Highmark, Elevance, and others) with documented success in improving HEDIS compliance and patient access to bone health screening. Products are described as portable, user-friendly, non-invasive, and cost-effective compared to traditional DEXA scanning. No specific FDA 510(k) numbers, ISO certifications, or CE marks are mentioned in the fetched content.

Mirion Technologies is a global provider of radiation detection, measurement, and safety solutions serving nuclear power operations, medical imaging and cancer care, occupational dosimetry, and environmental radiochemistry. The company specializes in radiological instrumentation, personal and area dosimetry products, radiation survey monitoring equipment, and supervisory software platforms. Key product lines include the Vital® Supervision platform (centralized radiological instrumentation management), CSPevo® Probe Family (portable radiation survey monitoring), Instadose®VUE (wireless personal dosimeters), and FRAM isotopic analysis systems. Mirion serves nuclear utilities, medical oncology centers, radiopharmaceutical manufacturers, research institutions (including the IAEA), and government agencies including NASA. The company provides training courses in radiation measurement and equipment operation, hosts industry conferences (Mirion Connect), and maintains service and support capabilities across multiple markets. Recent acquisitions and partnerships (Paragon Energy Solutions, Certrec) expand capabilities in nuclear licensing and infrastructure. Mirion's dosimetry products are used by healthcare workers and space program personnel (NASA Artemis missions).

UprightVR Inc. develops an FDA-registered, immersive virtual reality system for balance assessment, rehabilitation, and fall prevention. The platform combines VR technology with neuroscience-based diagnostics to measure sensory-motor integration and vestibular function in 8 minutes, generating detailed clinical and patient reports. Primary markets include physical therapy clinics, senior living communities, rehabilitation hospitals, and medical practices. The system includes RecoVR™ therapeutic rehabilitation modules—gamified exercises designed for patients with concussions, strokes, balance disorders, Parkinson's disease, cerebellar ataxia, hearing and balance impairments, and post-injury recovery. Assessment tools include SafetyNet™ for detecting hidden balance deficits and VOR (vestibular ocular reflex) retraining games. The company emphasizes portable, affordable deployment requiring minimal space and setup. Revenue model targets higher insurance reimbursement rates for advanced balance assessment and therapy. Developed by Geoffrey Wright, Ph.D., Professor of Neuromotor Sciences at Temple University, with two decades of clinical research validation across diverse patient populations. Offers comprehensive customer support including onboarding, remote and on-site training, clinical consultations, and data analytics. Continuous software updates add new assessments and rehabilitation modules.

Dexcom, Inc. is a leader in continuous glucose monitoring (CGM) systems and glucose biosensing technology, founded in 1999 and headquartered in San Diego, California. The company develops real-time glucose sensing devices that transmit glucose readings directly to smartphones and receivers, enabling people with diabetes to monitor their blood glucose levels continuously and make informed treatment decisions. Dexcom's primary product line includes the Dexcom G7 CGM System and the Dexcom G7 15 Day sensor, designed for adults 18+ with all types of diabetes. The G7 offers best-in-class accuracy and an extended 15-day wear period, with approximately 74% of sensors lasting the full duration. The company also offers Stelo Glucose Biosensor, an over-the-counter (OTC) integrated CGM intended for people 18+ not on insulin, including those with prediabetes or seeking general wellness optimization. Stelo requires no prescription, no fingersticks, and delivers personal glucose insights to users' phones. Dexcom's ecosystem includes connectivity with multiple smart devices and partner integrations to reduce the burden of diabetes management. The company serves patients across multiple insurance channels including commercial, Medicare Advantage, Medicare, Medicaid, VA Health Care, and Kaiser, as well as uninsured/cash-pay patients. Dexcom maintains FDA 510(k) clearance and regulatory compliance for its medical devices and supports healthcare providers through a dedicated provider portal. Manufacturing and distribution capabilities include pharmacy and medical supplier channels.

Gobiquity, Inc. (operating as GoCheck Kids) develops a smartphone-based pediatric hearing and vision screening platform that integrates photoscreening, visual acuity testing, and pure tone audiometry on a single mobile device. The platform is cloud-based and integrates with leading EHR systems, including eFax functionality for seamless clinical workflows. GoCheck Kids is designed for pediatricians, primary care clinics, schools, Head Start programs, and Federally Qualified Health Centers. The device meets American Academy of Pediatrics (AAP), American Academy of Pediatric Ophthalmology and Strabismus (AAPOS), and American Academy of Ophthalmology (AAO) recommendations for comprehensive child vision and hearing screening. The platform operates on a subscription model with no capital expenditure required. Customers may be eligible for reimbursement through vision procedure codes 99173, 99174, and 99177, and hearing procedure code 92551. The solution has been deployed across thousands of pediatric organizations and has screened over 7 million children. Key customers include Nemours, Norton Children's Hospital, CHOC Children's, Sutter Health, and Cook Children's Medical Center. The platform emphasizes workflow efficiency, improved care quality metrics, patient and family satisfaction, and early identification of hearing and vision disorders in children.

Entegrion, Inc. is a life sciences company specializing in viscoelastic coagulation monitoring (VCM) systems for rapid hemostasis assessment. The company develops point-of-care diagnostic instruments designed to measure blood coagulation in real-time, enabling clinicians to manage hemostasis and coagulopathies across trauma, surgery, obstetrics, and emergency medicine settings. The VCM system uses fully automated testing with fresh whole blood—no chemical accelerants or sample manipulation required—making it suitable for bedside and pre-hospital applications. The device features a portable footprint optimized for multiple clinical environments. Entegrion's products address both civilian and military medicine needs; the U.S. Department of Defense has invested over $100 million in the company's product development since inception. The VCM has achieved CE Mark regulatory clearance in Europe and other regions accepting CE-marked devices; however, it has not yet received FDA 510(k) clearance for human clinical use in the United States. The company also offers VCMVet for veterinary coagulation monitoring and VCM Cascade for human applications. Leadership includes experienced healthcare executives and clinicians with backgrounds in emergency medicine, hematology, laboratory diagnostics, and transfusion medicine. The organization combines R&D, clinical validation, and regulatory expertise to bring complex laboratory tests to point-of-care settings.

Perimed AB is a Swedish medical device manufacturer specializing in noninvasive vascular diagnostics and microcirculation assessment. Founded in the early 1980s, the company leverages laser Doppler flowmetry and laser speckle contrast imaging (LSCI) technologies to measure blood perfusion, microcirculation, and oxygen delivery in clinical and research settings. The company offers two primary product lines: PeriFlux systems for comprehensive vascular assessment (measuring toe pressure, segmental limb pressure, transcutaneous oxygen pressure, and skin perfusion pressure) and PeriCam systems for real-time perfusion imaging. Key instruments include the PeriFlux 6000 Combined System, PeriFlux 6000 EPOS (Enhanced Perfusion and Oxygen Saturation), and PeriCam PSI NR (on mobile cart for clinical and surgical use). Applications span diabetic foot complications, peripheral artery disease (PAD), wound healing assessment, hyperbaric oxygen therapy monitoring, dermatology, and preclinical research including cerebral blood flow monitoring, angiogenesis, hindlimb ischemia, and tumor models. The company maintains a US office in Las Vegas, Nevada, and headquarters in Järfälla, Sweden. Products are designed for clinical diagnosis, treatment planning, research protocols, and long-term therapeutic monitoring. The technology enables noninvasive, contact-free measurement with real-time visualization and comprehensive reporting capabilities.

Medispec Puerto Rico is a medical equipment distributor, rental, and service provider operating for over 10 years in the Caribbean region. The company specializes in supplying advanced diagnostic, surgical, and specialty medical equipment across multiple clinical disciplines including Ophthalmology, Radiology, Cardiology, Urology, Orthopedics, ENT, Neurosurgery, and Pain Management. Medispec maintains partnerships with leading global manufacturers (Zeiss, Genoray, Esaote, Canon, NSK, Nanosonics, and others) and offers comprehensive solutions covering diagnostic imaging systems, surgical microscopes, ultrasound equipment, sterilization systems, and clinical monitoring devices. The company emphasizes integrity, quality, and customer support through sales, equipment rental, and technical servicing for hospital systems and specialty practices throughout Puerto Rico.

Otsuka Medical Devices Co., Ltd. (OMD) is a Japanese medical device manufacturer specializing in minimally invasive endovascular therapies and innovative treatment solutions. Operating from Tokyo with the HARUMI Technology Center serving as a global R&D and training hub, OMD develops products for high-need disease areas including cardiovascular and oncology applications. The company combines Otsuka Group's pharmaceutical expertise with advanced device technology to address treatment-resistant conditions and diseases lacking effective therapeutic options. ISO 13485:2016 certified for vascular stents and ultrasound renal denervation systems. Key product platforms include the Paradise System for ultrasound-guided renal denervation, BioMimics 3D peripheral artery stent for complex vascular anatomy, and Tron FX thrombectomy device for acute vascular interventions. OMD maintains a global research and development infrastructure to advance endovascular therapy, apheresis technologies, and photodynamic therapy approaches.

Chematics, Inc. manufactures point-of-care diagnostic products for alcohol and cholesterol screening, serving healthcare providers, occupational/industrial testing programs, and home-use consumers. Established in 1988, the company specializes in cost-effective, rapid diagnostic tests that enable early health problem detection and support self-directed health monitoring. Primary product lines include Alco-Screen® saliva alcohol tests for BAC estimation and Chemcard™ fingerstick cholesterol screening tests. All products are manufactured in the USA and feature FDA 510(k) clearance and CLIA waiver status, indicating regulatory compliance for clinical laboratory use. The company also supplies Alcohol Oxidase reagents for laboratory applications. Chematics serves institutional buyers (physician offices, industrial safety programs), point-of-care testing environments, and direct-to-consumer markets. The company emphasizes accessibility and affordability in diagnostic screening while maintaining quality and accuracy standards.

Team Technologies, Inc. (rebranding as Cordica Medical as of January 2026) is a comprehensive medical device manufacturer and contract development and manufacturing organization (CDMO) headquartered in Knoxville, Tennessee. The company operates across multiple therapeutic and product categories, serving the diagnostic, surgical, and therapeutic markets with proprietary and contract manufacturing capabilities. Core product lines include: interventional cardiology and neurovascular catheter-based devices; in vitro diagnostic (IVD) testing and lateral flow assays; wearable patient monitoring sensors; advanced wound care products; infection control and PPE solutions (including privacy curtains, disposable apparel, and accessory products); pharmaceutical delivery and dosing systems; patient handling and mobility solutions; and dental/oral care products (toothbrushes, prophy angles, prophylaxis supplies). Manufacturing capabilities span product design and rapid prototyping, catheter extrusion and assembly, precision medical tubing, injection and blow molding, textile converting, RF welding, advanced bristling and tufting, wet and dry chemistry formulation, sewing and textile processing, and value-added customization. The company operates under ISO 13485 and FDA-regulated guidelines. U.S.-based manufacturing and supply chain operations support medical device OEMs and diagnostic companies from concept through commercialization. Specialty product brands include ICP Medical (privacy curtains/PPE), Rapid Refresh, Protexer, Bootie Butler, Topi-CLICK dosing applicators, AllPro dental supplies, PDS and PHB toothbrushes, and Prophy Perfect prophy angles.

bioMérieux is a global in vitro diagnostics leader headquartered in France, with significant US operations. The company manufactures and distributes comprehensive diagnostic solutions for clinical microbiology, molecular pathology, blood culture detection, immunoassays, and rapid point-of-care testing. Core competencies span microbial identification and antimicrobial susceptibility testing (ID/AST), sepsis diagnosis and management, infectious disease detection (respiratory pathogens, gastrointestinal pathogens), and blood culture systems. Key product platforms include BIOFIRE® FILMARRAY® multiplex PCR systems, VITEK® MS PRIME mass spectrometry, BACT/ALERT® VIRTUO® blood culture automation, and VIDAS® immunoassay analyzers. The company also serves pharmaceutical and food safety markets with quality control and environmental monitoring solutions. bioMérieux addresses critical clinical challenges including antimicrobial resistance (AMR) stewardship, rapid sepsis identification, and respiratory infection diagnostics. Offerings span hospital laboratories, point-of-care settings, and industrial applications. The company emphasizes diagnostic-driven clinical decision support, workflow automation, and integrated laboratory information management. Manufacturing includes automated detection systems, rapid molecular platforms, and MALDI-TOF mass spectrometry instruments. US operations distribute test kits, reagents, and instruments through multiple channels including direct sales and the bioMérieux eShop. The company holds multiple regulatory clearances including FDA 510(k) approvals and CE marking for diagnostic instruments and test kits.

Aidar Health designs and develops clinically validated digital medicine software platforms and breath- and saliva-based biosensors for precision disease management across therapeutic areas including respiratory, renal, infectious, cardiovascular, and oncology. The company operates three primary product lines: Aidar Connect (clinician web application for remote patient monitoring and care coordination), MouthLab (medical device for biosensor data collection), and Aidar Care (patient mobile application). Aidar serves multiple market segments through specialized service offerings: Long-Term Care (remote physiological monitoring, chronic care management, transitional care management, hospital-at-home programs); Life Sciences (digital biomarkers, digital companions, decentralized clinical trials, real-world evidence collection); and Population Health Management for payers. The platform enables objective, non-invasive assessment of clinical status, facilitates early disease detection, supports treatment optimization, and enables risk stratification to reduce readmissions and emergency department utilization. Aidar has received FDA clearance for its breath-based medical device and maintains partnerships with major research institutions (NIH, Johns Hopkins, VA) and government agencies (BARDA, NSF). The company targets clinical outcomes improvement and cost reduction through digital-first precision medicine approaches suitable for aging populations and chronic disease management.

Evergreen International Group (EIG) is a California-based medical supply distributor serving skilled nursing facilities (SNFs) and healthcare providers across the state. Founded as a small West Los Angeles operation serving Eva Care Groups' facilities, EIG has expanded to serve over 300 facilities with distribution centers in Hayward and Monterey Park. The company specializes in infection control consumables, personal protective equipment (PPE), cleaning and disinfection products, first aid supplies, and medical apparel. Product offerings include disposable face masks (earloop and cloth varieties), examination gloves (vinyl), isolation gowns with ties, infrared thermometers, and commercial-grade disinfectants such as Clorox solutions. EIG operates a B2B e-commerce platform (eigshop.com) serving institutional customers with pricing, bulk ordering, and warehousing capabilities. The company emphasizes localized, personalized customer service with regional availability and free shipping on orders exceeding $50 within California. Operations span Monday–Friday business hours across head office and warehouse locations. EIG's market focus remains the skilled nursing home sector within California, though the online platform enables broader institutional reach.

Tekscan, Inc. designs and manufactures patented force measurement, pressure mapping, and tactile sensing solutions for clinical, research, and industrial applications. The company specializes in real-time pressure and temperature visualization systems used to measure and analyze force distribution between or across surfaces. Core product lines include pressure mapping systems for clinical assessment and R&D optimization, embedded flexible force sensors (FlexiForce) engineered for OEM device integration, and temperature mapping systems that correlate thermal and pressure data. A key clinical product is T-Scan Novus, a digital occlusal analysis system for dental applications that evaluates bite force, occlusion, and timing. Tekscan's solutions serve biomechanics research, dental diagnostics, orthopedic assessment, rehabilitation evaluation, automotive and manufacturing quality control, battery optimization, and electronics/semiconductor process validation. The company provides custom sensor design, rapid prototyping, and engineering consultation through TactileLab. Products are used by clinicians to improve patient outcomes and by engineers in R&D and quality control to validate designs and ensure repeatable performance. Tekscan was acquired by Uneo, Inc. in November 2025 and operates as part of the Tekscan Group. The company maintains technical support services, product training, and calibration capabilities.

Werfen is a global in vitro diagnostics company operating directly in over 30 countries and through distributors in more than 100 territories. The company develops, manufactures, and commercializes diagnostic systems, reagents, software, and services across hemostasis, acute care diagnostics, transfusion, autoimmunity, transplant, immunoassay, and clinical chemistry. Werfen's hemostasis portfolio includes in vitro diagnostic systems and reagents for diagnosing and guiding treatment of thrombotic and bleeding disorders. The acute care diagnostics line provides integrated whole-blood testing solutions for cardiovascular operating rooms, catheterization laboratories, intensive care units, and emergency departments. The transfusion division offers manual and automated solutions with serology reagents, fully automated instrumentation, data management software, and molecular products for donor-recipient compatibility. The autoimmunity segment delivers reagents and lab automation for diagnosing and monitoring autoimmune diseases. Transplant products feature molecular and antibody-based HLA assays and software for pretransplant compatibility determination and post-transplant monitoring. Clinical chemistry solutions serve chemistry and pharma-toxicology laboratories. Werfen also recently completed the acquisition of Omixon, a Budapest-based company specializing in next-generation sequencing technologies for transplant diagnostics. The company maintains a technology center in Bedford, Massachusetts, expanded in December 2024. Werfen's solutions are designed to improve patient care quality, reduce laboratory costs, ensure regulatory compliance, and enhance operational efficiency across clinical laboratory and acute care hospital settings.

FIGUR8, Inc. develops FDA-registered musculoskeletal (MSK) assessment technology that replaces subjective measurement tools with objective, lab-grade biomechanics data. The company's flagship platform, the bioMotion Assessment Platform (bMAP), combines on-body wearable sensors with cloud-based analytics to provide precise movement analysis and functional capacity assessments. FIGUR8 serves physical therapists, orthopedic surgeons, chiropractors, occupational health clinics, workers' compensation payers, and sports medicine practitioners. The platform captures over one million data points during dynamic functional movement testing, offering quantitative metrics for injury assessment, recovery monitoring, and return-to-work determination. Use cases include workers' compensation claim management, surgical candidacy evaluation, post-injury rehabilitation tracking, and athletic performance assessment. FIGUR8 is particularly positioned for workers' compensation and occupational health markets, where objective MSK data reduces claim duration and improves outcomes. The company emphasizes clinical training and provider enablement through didactic courses and onsite support. Regulatory status includes FDA registration; the site references compliance with clinical standards and the APTA Digital Transparency Pledge. The technology addresses a significant clinical gap by providing consistent, repeatable objective metrics superior to manual muscle testing and traditional subjective clinical assessments.

Bell Medical, Inc. is a specialized distributor and service provider of anesthesia equipment, supplies, and biomed services established in 1975. The company operates as an exclusive distributor for major anesthesia manufacturers including Armstrong Medical, Amsorb Plus CO2 Absorbent, Heine, Propper, Rusch, Sunmed, Upsher, and others. Product portfolio encompasses anesthesia machines (GE Healthcare, Drager, Penlon, Datascope, Mindray, Ohmeda legacy models), laryngoscopes and blades, endotracheal tubes (Parker Flex-Tip), nerve stimulators with train-of-four monitoring (Stimpod 450X+ with AMG/EMG capabilities), supraglottic airways (AES brand), spinal needles (IMD Gertie Marx), oxygen sensors (Ceramatec, Analytical), temperature indicators (Clinitemp), ultrasound probe covers (Safersonic), and difficult airway management systems (Insight System, Eschmann Stylet). Bell Medical provides preventive and emergency service and maintenance for anesthesia machines, parts supply, and general biomedical services across Illinois to Utah. The Stimpod 450X+ represents their flagship neuromuscular monitoring product, featuring dual AMG/EMG technology for cost-effective blockade monitoring at point-of-care. Company also stocks medical carts (MPD brand), cardiopulmonary monitors (Schiller, Criticare), and addresses emerging clinical needs such as subglottic endotracheal tubes (NEVAP) for aspiration prevention in GLP-1 agonist users.

Thinklabs Medical manufactures digital stethoscopes designed for clinical auscultation and telemedicine integration. The company's flagship product, the Thinklabs One Digital Stethoscope, features 100x audio amplification with five precision filter options, enabling clinicians to isolate and enhance cardiac, pulmonary, and other body sounds. The device includes rechargeable battery technology (100–120 patient exams per charge), Bluetooth and wired connectivity to most headphones and telemedicine platforms, and integrates seamlessly with major EHR and telemedicine software including Zoom, Cisco WebEx, Teladoc, American Well, and other systems without requiring screen switching during patient consultation. The stethoscope is used across 50+ countries and seven continents in primary care, cardiology, pulmonology, nursing, education, critical care, emergency medicine, pediatrics, NICU, anesthesiology, hospice, research, veterinary, and government/military settings. Marketed as a device for both clinical diagnostics and enhanced hearing accessibility for audiologists and hard-of-hearing practitioners, Thinklabs stethoscopes are employed in hospitals, FQHCs, acute care facilities, clinical trials, school-based health programs, and workplace health initiatives. The company emphasizes precision audio engineering and clinical utility without proprietary ecosystems, enabling broad deployment across institutional and private practice settings.

NeurOptics is a worldwide leader in pupillometry technology for critical care, neurology, neurosurgery, emergency medicine, and applied research. The company develops and markets the NPi-300 Pupillometer, a handheld device that provides objective, quantitative assessment of pupil size and reactivity independent of examiner variability. The NPi-300 is adopted in over 1,000 U.S. hospitals and represented in more than 50 countries globally. The device measures pupillary responses and constriction velocity, enabling clinicians to detect subtle changes in pupillary response that may indicate increased intracranial pressure, neurological decline, or brain injury—particularly valuable in sedated or comatose patients where subjective penlight examination is unreliable. NeurOptics also provides pupillometry instrumentation for applied research applications, supporting both human and animal research across various clinical and research settings. The company emphasizes device integration with electronic medical records (EMR) to streamline clinical workflows and enable trend analysis of pupillary data as a vital sign. The NPi-300 is used extensively in neurocritical care units, stroke services, trauma centers, and cardiac arrest care settings. Clinical evidence supports the device in management of traumatic brain injury, cardiac arrest, malignant cerebral edema, and assessment for brain death determination.

Neko Health AB operates a preventive health screening service offering comprehensive full-body health assessments conducted at dedicated health centres. The company uses advanced multimodal scanning technology to capture measurements across body composition, blood vessels, heart rhythm, immune system markers, metabolism, and peripheral arteries, generating actionable health data within minutes. Clinical results are delivered immediately to patients with unrushed physician consultation included in the service. The company operates a doctor-led model of care emphasizing longitudinal health tracking and early disease detection through annual benchmark comparisons. Operating locations include four health centres in London (Covent Garden, Marylebone, Spitalfields, Victoria), one in Manchester (Lincoln Square), one in Birmingham (Colmore Row), and one in Stockholm (Östermalmstorg), with plans for expansion. Services are priced at £299 per scan. The organization collects aggregated health data for research purposes and maintains a membership model. Neko Health focuses on preventive medicine and wellness monitoring for health-conscious individuals seeking proactive health management rather than reactive clinical intervention.

Thermomedics, Inc. manufactures the CAREGIVER® Clinical Grade Non-Contact Infrared Thermometer (NCIT), a non-contact forehead thermometer developed by the team that invented tympanic thermometry. Introduced over 13 years ago, the CAREGIVER® has become the primary offering for hospitals, clinics, schools, and first-responder/rescue situations for measurement of forehead temperature in adults, children, and infants. The device delivers measurement results in 1–2 seconds with documented clinical precision and operates with AA battery power sufficient for up to 15,000 temperature measurements. Key features include non-contact infrared technology that eliminates probe covers and cross-contamination risk, bright backlit display with 30-temperature memory recall, one-button operation, and multi-task capability to measure room temperature and skin/surface temperature. The thermometer is rugged for routine hospital/clinical handling and is offered through major GPOs, IDNs, and supply chain leaders including VIZIENT, HPG, KAISER, NDC, McKesson, KentecAmerican, and a national network of regional healthcare dealers. Accessory offerings include wall-mount models, calibration verification systems, and secure tether models. The company supports clinical professionals with industry-leading customer service, product registration, and a comprehensive system of optional accessories for hospital/clinical management of efficient, safe, and accurate vital signs measurement.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.

AccuVein is a medical device manufacturer specializing in near-infrared (NIR) vein visualization technology for vascular access procedures. The company develops handheld vein finder devices that enable healthcare professionals to visualize peripheral veins, valves, and bifurcations not visible to the naked eye, improving peripheral IV catheter placement success rates and reducing procedure time and complications. AccuVein's primary products serve acute care settings (emergency departments, ICUs, general wards), non-acute care environments (outpatient clinics, home care), and aesthetic/cosmetic medicine practices. Clinical evidence supports the technology with 92% first-attempt success rates for IV placement, 78% reduction in procedure time, 45% decrease in escalation calls, and 39% reduction in patient pain. The company manufactures multiple generations of vein visualization devices, including the AV500, AV600 (fourth-generation model recently launched), and associated accessories such as the HF580 Powered Stand for hands-free mobile applications. AccuVein's devices are recommended by leading professional societies for pre-insertion vascular assessment and are positioned to improve clinical outcomes, operational efficiency, staff well-being, and healthcare equity by enabling successful venous access across diverse patient populations.

Silex Global LLC is a healthcare and household products provider founded in 2014, operating across the United States, Canada, Mexico, and Europe. The company markets medical devices and wellness products under its Paramed brand, which specializes in both professional and domestic healthcare applications. Paramed's primary product lines include automatic and mechanical blood pressure monitors, digital and analog thermometers, and stethoscopes. All Paramed products are FDA-approved, CE-certified, and meet ISO standards. The company reports annual sales exceeding 100,000 blood pressure monitors, 10,000 thermometers, and 20,000 stethoscopes, serving more than 50,000 customers. Silex Global positions itself as a B2B supplier targeting distribution and retail companies seeking long-term partnerships. Products are designed for ease of use, portability, and advanced functionality, with independent testing and quality assurance prior to market release. The company emphasizes customer-centric service, rapid response times, and responsibility for product quality as core business values.

BKMed Store is a Brooklyn-based medical equipment and consumables supplier serving clinics, pharmacies, and healthcare professionals in the New York area. The company stocks a comprehensive range of surgical instruments, diagnostic tools, and disposable medical supplies. Product categories include surgical sutures, staplers and sealers, surgical trocars, catheters and guidewires, clips and appliers, orthopedic surgical consumables, and wound management supplies. The company also carries portable ultrasound machines, patient monitoring cables and sensors, respiratory circuits and filters, and orthopedic devices. BKMed Store partners with major manufacturers including Ethicon, Covidien, Stryker, Aesculap, BD, Philips, and Respironics. Services include fast local delivery to Brooklyn and surrounding areas, competitive bulk pricing for healthcare facilities, and direct support for professional procurement. The company operates as a B2B medical supplier focusing on consumables, replacement parts, and compatible accessories rather than primary diagnostic or surgical equipment.

Zepp Health is a consumer health technology company delivering smart wearable healthcare solutions and digital health management platforms. The company manufactures intelligent wearables including smartwatches, smart bands, and smart hearing devices capable of continuous 24/7 health monitoring and biometric data collection. The Zepp Digital Health Management Platform integrates proprietary Zepp OS, AI chips, biometric sensors, and data algorithms to provide cloud-based actionable health insights and personalized wellness guidance. Key capabilities include real-time physiological monitoring, AI-driven sports and sleep coaching, atrial fibrillation detection (with 135,000+ suspected AFib events detected), and generative AI solutions utilizing Large Language Models for natural language interaction. The platform delivers preventative care insights and enables users to understand their health data for informed decision-making. Zepp Health serves a global consumer market with 42+ million active users across 90+ countries and has shipped over 200 million units worldwide. The company collaborates with 25+ world-class research partners and combines audiologist expertise with wearable technology for hearing solutions. Products feature proprietary sensors and algorithms optimized for continuous health tracking, fitness monitoring, sleep analysis, and wellness optimization across consumer segments.

Kinvent develops connected biomechanical assessment devices and software for rehabilitation, sports performance, clinical diagnosis, and research. The company specializes in real-time measurement of strength, balance, mobility, and neuromuscular function through a suite of portable, sensor-based products. Their device portfolio includes force plates (K-Deltas, K-Deltas XL, 3D Deltas, K-Force Plates), handheld and fixed dynamometers (K-Push, K-Pull, K-Grip, K-Bubble), motion sensors (K-Move for goniometry, K-Power for gait and speed analysis), and surface EMG sensors (K-Myo). All devices integrate with a HIPAA-compliant software platform for data capture, analysis, and patient progress tracking. Kinvent targets physical therapists, sports performance coaches, physicians, orthopedic specialists, and researchers. The platform supports objective assessments for return-to-sport testing, rehabilitation outcome measurement, injury prevention, and performance optimization. The company serves professional sports teams (including MLB's Cleveland Guardians), academic medical centers (Hospital for Special Surgery, Weill Cornell Medicine, Stanford Health Care), and research institutions. Products are used for ACL rehabilitation, lower-back pain assessment, ankle sprain management, gait analysis, vertical jump assessment, grip strength evaluation, and neuromuscular symmetry testing.

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Owlet Baby Care designs and manufactures FDA-cleared smart baby monitoring systems for home and clinical use. The company's primary product lines include Dream Sock (an FDA-cleared wearable pulse oximeter and heart rate monitor), Dream Duo (an integrated monitoring system combining wearable sock with video monitoring), and Dream Sight (an HD video baby monitor). For medical professionals, Owlet offers BabySat, a hospital-grade, prescription-only monitoring device designed for higher-acuity patient populations. All products provide real-time vital sign monitoring (pulse rate, oxygen saturation), sleep analytics, and alert notifications. Owlet's technology integrates continuous medical-grade sensor readings with mobile app interfaces delivering personalized, age-appropriate wellness insights. The company serves both consumer parents and healthcare providers, with clinical-grade devices available through prescription via medical channels (Adapt Health). Owlet maintains FDA 510(k) clearance for its monitoring devices and publishes peer-reviewed clinical research and white papers. The firm also operates Owlet360, a subscription service providing extended personalized analytics, and Owlet Cares, a community advocacy and research initiative. Based in Lehi, Utah, Owlet positions itself in the early parenting care and home monitoring segment, combining consumer accessibility with clinical credibility.

Ametris (formerly ActiGraph) is a digital health technology (DHT) company specializing in wearable medical devices and remote monitoring platforms for clinical research and drug development. The company provides FDA-cleared, medical-grade wearable devices paired with a scalable remote monitoring platform to capture objective, real-world patient data across multiple clinical domains. Ametris delivers an integrated, end-to-end solution combining hardware, cloud-based software, proprietary algorithms, and comprehensive operational and scientific support services. Core measurement capabilities include physical activity, gait and mobility analysis, sleep behavior monitoring, vital signs tracking, and cardinal symptom assessment. The platform is purpose-built to support all phases of the clinical trial lifecycle—from study design and site training to data collection, processing, archiving, and real-time monitoring. Ametris has established expertise in neuromuscular disorders, oncology, neuroscience, sleep medicine, and metabolic diseases. The company serves pharmaceutical sponsors, biotechnology firms, clinical research organizations (CROs), academic institutions, and hospital research networks across 150+ countries. With over 20 years of remote data capture expertise, 30,000+ peer-reviewed scientific publications supporting its technologies, and operational involvement in 285+ industry-sponsored clinical trials, Ametris positions itself as a scientific partner rather than a technology vendor alone. Services include endpoint design consultation, algorithm validation, regulatory strategy support, and DHT data interpretation. The company maintains headquarters in Pensacola, Florida, and operates a global support infrastructure with 24-hour critical support availability.

ACON Laboratories, Inc. is a US FDA-registered global medical device manufacturer specializing in point-of-care testing (POCT) and immunoassay products. Headquartered in San Diego, California, the company develops and manufactures diagnostic solutions across four primary product lines: Point of Care, Immunoassays, Molecular Diagnostics, and Animal Health. Products serve hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics worldwide. The On Call® Blood Glucose Meter Family is designed for glucose monitoring and diabetes management. Mission® brand includes urine reagent test strips, urine analyzers, and handheld devices for cholesterol, coagulation, and hemoglobin measurement. HealthyMe® provides urinary tract infection (UTI) detection reagent strips. Flow flex® is the newest lateral flow rapid testing brand, offering multiplexed home tests including the recently FDA 510(k)-cleared Flow flex® Plus RSV + Flu A/B + COVID multiplex rapid antigen test for ages 6 months and up. The company's ACON brand offers lateral flow rapid tests for pregnancy, cancer markers, and infectious disease screening, including SARS-CoV-2 antibody and antigen tests. Distinct® provides pregnancy rapid tests using qualitative chromatographic immunoassays. Foresight® offers allergen immunoblot testing for 30 allergens on a single strip. Promotor® provides nucleic acid extraction systems and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV genotyping, tuberculosis, and HLA-B27. CentriVet® serves veterinary diagnostics with dual ketone/glucose meters and urine reagent strips. ACON maintains US FDA registration, provides contract manufacturing and OEM services, and holds multiple FDA 510(k) clearances for its diagnostic products.

Integrated Medcraft LLC is a B2B medical distributor and supplier specializing in emergency medical equipment, trauma care supplies, and field medical solutions. The company serves Veterans Affairs, law enforcement, EMS, and military/tactical communities, with a DLA ECAT contract (SPE2DV-24-D-0017) indicating federal government qualification. Product lines include: hemorrhage control and trauma supplies (TrueClot brand hemostatic products), thoracic trauma management (chest seals), patient warming and transportation equipment, splinting and immobilization devices, airway management tools, transfusion and medication delivery systems, monitoring and diagnostic equipment, surgical and wound closure supplies, and training supplies with anatomical manikins. The company distributes multiple branded product lines including FORWARD (IFAKs and field procedure kits), APLS, TrueClot, and represents partners including Halo Seal, RevMedX, Nonin, SAM Medical, Teleflex, Compression Works, and others. Integrated Medcraft operates as a reseller and distributor rather than a manufacturer, curating emergency medical equipment for tactical, pre-hospital, and institutional use. The company emphasizes domestically-made products (TrueClot is USA-manufactured) and offers customizable trauma kits. Marketing targets military personnel, first responders, and government procurement with imagery emphasizing veterans and community service. The company provides downloadable product catalogs, buyers guides with NSN (National Stock Numbers), and federal contract documentation.

BLOXR Solutions is a USA-based manufacturer of proprietary scatter radiation protection products, including non-lead X-ray aprons, vests, skirts, thyroid collars, and specialized protective garments. The company's patented XPF technology combines barium sulfate and bismuth oxide to deliver 0.5 mm lead equivalent attenuation without lead, tungsten, or toxic heavy metals. Product portfolio includes frontal aprons, 2-piece vest-and-skirt sets, thyroid collars and caps, breast protection inserts, pregnancy shields, shin guards, arm sleeves, eyewear, mobile shields, and ULTRABLOX attenuating hand cream. BLOXR serves hospitals, surgical centers, cardiac catheterization labs, interventional radiology departments, orthopedic facilities, imaging centers, veterinary practices, and dental offices. All garments feature customization options including monogramming, logo embroidery, and dosimeter pockets. Manufacturing is USA-based. Products are independently validated for radiation attenuation and designed to reduce occupational exposure for clinicians and patients during fluoroscopic, interventional, and radiographic procedures.

Ondal Medical Systems GmbH is a global manufacturer of suspension arm systems and medical pendant carrier systems for hospitals, operating rooms, intensive care units, and diagnostic imaging areas. Founded in 1945 and headquartered in Hünfeld, Germany, the company operates as a B2B supplier specializing in customized ODM/OEM solutions for hospital suppliers and medical technology companies. With over 3 million suspension arms installed in approximately 70% of hospitals worldwide, Ondal designs and manufactures medical device suspension systems, surgical light positioning systems, medical display mounting solutions, and ceiling-mounted supply units. The company holds CE and UL certifications and complies with ISO 13485 medical device standards. Ondal provides comprehensive services including installation, maintenance, repairs, technical support, and product training through a dedicated Technical Service Department. Their solutions optimize workflow efficiency and ergonomics across operating rooms, radiology departments, examination rooms, and ICU environments.

SCHILLER Americas is a cardiopulmonary diagnostic device manufacturer and solutions provider with 50 years of innovation in medical diagnostics. The company specializes in electrocardiography (EKG), lung function testing, patient monitoring systems, and diagnostic station equipment. Their product portfolio includes EKG devices, the DS-20 Diagnostic Station, lung function testing systems (including the TREMOFLO), and multiparameter patient monitoring solutions. SCHILLER serves multiple market segments: general practice clinics, hospitals, specialized lung function laboratories, and government distributors. The company emphasizes integration of device hardware, clinical software, and ergonomic user interface design under their "Art of Diagnostics" philosophy. They offer service solutions, equipment trials (SCHILLER Trial Program), and ADA-compliant device options to support accessible patient care. Based in Doral, Florida, SCHILLER Americas operates as the North American division of the SCHILLER Group, a globally recognized medical device manufacturer. Their solutions are deployed across primary care, acute care, pulmonary specialty, and occupational health settings.

Viasonix is a medical device manufacturer specializing in vascular and neuro-vascular diagnostics with over 30 years of experience. The company develops and manufactures Doppler ultrasound systems and pneumatic technology platforms serving clinical vascular assessment, transcranial Doppler (TCD) monitoring, and DVT prevention in home care settings. Core product families include the Falcon line for peripheral vascular physiologic diagnosis (ABI, PVR, segmental blood pressure, Doppler measurements), the Dolphin line for transcranial Doppler monitoring in neurosurgery, ICU, and stroke management, and the LiteWalk compression device for venous stasis prevention. All products are manufactured in-house with ISO 13485 certification and multiple regulatory approvals (FDA, CE, TFDA, CFDA, KFDA, ANVISA, INVIMA, NMPA, TGA, and others). The company supplies over 50 distributors worldwide.

IDMED develops and markets innovative medical devices for anesthesia and intensive care monitoring. The company specializes in automated pupillometry and neuromuscular transmission (NMT) monitoring solutions used globally in operating rooms and ICU settings. The NeuroLight® pupillometer provides accurate, automated measurement of pupil size and reactivity for neurological assessment and prognostication in intensive care environments. The ToFscan® is a quantitative neuromuscular blockade monitor utilizing three-dimensional sensors with a wide sensor range and requires no pre-use calibration. Both products are designed to enhance clinical decision-making and patient safety in perioperative and critical care settings. IDMED's focus on neurological and neuromuscular monitoring positions the company within the specialty diagnostic and patient monitoring equipment segment, serving anesthesiology, critical care, and neurology departments.

Bio-Nuclear of PR, Inc is a premier supplier of medical and laboratory equipment serving healthcare providers, laboratories, and patient care facilities across Puerto Rico and the Caribbean for over three decades. The company distributes a comprehensive range of clinical diagnostic equipment, healthcare solutions including bone densitometry and ultrasound systems, anatomical pathology instruments, and reference laboratory solutions designed for high-volume sample processing. Bio-Nuclear partners with major manufacturers including GE HealthCare and Sysmex, providing access to cutting-edge diagnostic technologies. The company's product portfolio encompasses clinical diagnostic systems with precision and reliability for clinical diagnosis, patient care solutions customized for superior patient experience, vanguard pathology technologies for precise diagnosis, and workflow solutions tailored for large-volume laboratory operations. Bio-Nuclear serves hospitals, diagnostic centers, reference laboratories, and industrial applications across the Caribbean region. The company maintains a customer service infrastructure and supports various healthcare professionals including laboratory directors, managers, biomedical technicians, medical technologists, pathologists, sonographers, and purchasing agents.

PartsSource, Inc. is a B2B medical equipment parts and service distributor serving hospitals, clinics, and healthcare facilities across the United States. The company operates a comprehensive online marketplace specializing in replacement parts, consumables, repair services, and accessories for a broad range of diagnostic imaging, patient monitoring, respiratory, surgical, and facility maintenance equipment. PartsSource maintains inventory of OEM parts from leading manufacturers including GE Healthcare, Philips, Stryker, Mindray, Welch Allyn, CareFusion, and others. Product categories include ultrasound probes and transducers, ventilator components, batteries and power supplies, infusion pump accessories, fetal monitoring transducers, surgical table components, sterilization equipment filters, maintenance kits, and specialty cables and connectors. The company provides repair services for equipment such as GE Healthcare fetal transducers and probe disinfectors. PartsSource operates a searchable parts database organized by manufacturer, model, and device category (ultrasound, patient monitoring, respiratory, beds/furniture, radiographic imaging, MRI, X-ray, C-arms, catheterization lab, and facility maintenance). The platform supports procurement workflows with order tracking, shopping history, and direct contact for quotes. The company's tagline is "Ensuring Healthcare is Always On®," emphasizing focus on equipment uptime and operational continuity. No specific regulatory certifications (FDA, ISO) are explicitly stated on the home page, though the site indicates active partnerships with major OEM suppliers.

WatchRx is a digital healthcare platform built around smartwatch-enabled remote patient monitoring (RPM), chronic care management (CCM), transitional care management (TCM), and medication adherence solutions. The company provides an AI/ML-enabled cloud platform that integrates wearable technology to collect real-time patient vital signs and behavioral data, enabling clinicians to deliver proactive, value-based care and improve patient outcomes while reducing hospitalizations and urgent care visits. Primary markets include independent practices and primary care clinics, hospital systems, accountable care organizations (ACOs), and senior living and home care facilities. The platform automates clinical workflows, generates actionable insights for physicians, and supports medication adherence monitoring and GPS tracking for senior populations. Clinical evidence cited on the site demonstrates 76% reduction in hospitalizations, 51% reduction in urgent visits, and 90% patient satisfaction. The solution generates approximately $220+ additional revenue per patient per month through RPM/CCM billing codes. WatchRx partners with major healthcare networks and UnitedHealth Group. The company serves the growing market of value-based care delivery and remote monitoring, targeting reduction of healthcare costs and physician burnout while improving care coordination and patient engagement.

Werfen (formerly Immucor, Inc.) is a global leader in specialized diagnostics for transfusion and transplantation medicine. The company manufactures a comprehensive portfolio of serology-based reagents, automated instruments, and molecular diagnostic products serving blood banks, transfusion services, clinical laboratories, reference laboratories, donor centers, and transplant programs worldwide. Core product lines include: (1) Transfusion diagnostics—blood typing, antibody screening and identification, platelet serology, and HLA donor screening assays; (2) Transplant diagnostics—HLA typing kits (including NanoTYPE® HLA-11 Plus), HLA and non-HLA antibody detection products, and post-transplant monitoring assays; and (3) Coagulation diagnostics for heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP) detection. Signature automated platforms include the NEO® and NEO Iris® systems for immunohematology automation, and Echo Lumena® for antibody identification with enhanced imaging. The company acquired Omixon (Hungary) to expand HLA typing capabilities. Werfen operates globally across hospital blood banks, reference laboratories, and transplant centers, leveraging customer-centric support with field representatives who possess transfusion and transplant technical expertise. The company emphasizes regulatory compliance, quality assurance, and comprehensive technical and educational support to streamline laboratory workflows and improve patient outcomes in transfusion and transplant medicine.

Bedfont Scientific Ltd is a UK-based medical technology company founded in 1976 and headquartered in Harrietsham, Kent. As a second-generation family-owned business with over 48 years of experience, Bedfont specializes in designing, manufacturing, and distributing non-invasive breath and gas monitoring instruments for medical diagnostics. Operating in more than 76 countries through a network of over 100 distributors, the company is a recognized world leader in breath analysis technology. Bedfont's product portfolio includes the Smokerlyzer® series for smoking cessation via CO breath analysis, the NObreath® FeNO monitor for asthma diagnosis and airway inflammation management, the Gastrolyzer® range for detection of gastrointestinal disorders and food intolerances using hydrogen and methane breath testing, the Medi-Gas Check range for medical gas pipeline verification and quality assurance, the Breathacise® incentive spirometer for respiratory capacity training, and the CELLER8® device for clinical applications. The company emphasizes innovation in non-invasive diagnostics and has received multiple awards including Business of the Year 2024.

BioSensics is a wearable sensor and digital health technology company founded in 2007 by three Harvard University scientists. The company specializes in developing FDA-registered medical devices and digital biomarkers for clinical trials, remote patient monitoring, and health assessments, particularly for older adults and neurological disorders. BioSensics' core offerings include advanced fall detection and prevention systems with automatic fall alert capabilities, continuous monitoring of fall risk and physical activity, balance and gait assessment technologies, and cognitive function monitoring sensors. The company also provides the BioDigit Home platform, a centralized data aggregation system that integrates data from various digital health technologies. BioSensics has licensed its fall detection technology to major retailers and medical device manufacturers and provides comprehensive operational and technical services for clinical research across therapeutic areas including Alzheimer's disease, Parkinson's disease, and stroke. With over $50 million in NIH funding support, BioSensics has established itself as a leader in objective measurement of disease symptoms and validated biomarkers for clinical and research applications.

Solvemed Inc. develops PuRe™ Pupillometer, a smartphone-based FDA Class I medical device for objective pupillary assessment in critical care settings. The device employs computational pupillometry to measure pupil size and reactivity with superior accuracy across varying ambient light conditions—addressing a key limitation of conventional infrared pupillometers, which show significant measurement variability in different lighting environments. The PuRe™ score is a lighting-invariant metric derived from exposure-corrected pupillary parameters and is openly published for research benefit. The software integrates securely with major hospital EMR systems (Epic, Oracle, Athena, Meditech, Allscripts, eClinicalWorks) via HIPAA-compliant cloud infrastructure with SOC2 certification. The solution eliminates disposable costs and hardware logistics while providing immediate EMR data upload. Clinical collaborations span Emory Healthcare, NHS Oxford, Harvard-affiliated institutions, and UK research centers. Designed for neuro-ICU, medical-ICU, cardiac-ICU, surgical-ICU, trauma centers, stroke units, and emergency departments. No hardware required; operates on iOS devices with Face ID authentication. The device enables standardized, reproducible neurological assessment comparable to automated vital-sign measurement.

Radiometer Medical APS is a global acute care diagnostics company with over 70 years of industry experience. The company manufactures and integrates blood gas analyzers, point-of-care testing syringes, point-of-care IT solutions, and associated laboratory services. Operating across 59 countries with 3,780+ employees, Radiometer's portfolio addresses critical diagnostic workflows in hospitals and acute care settings. The company reports testing approximately 300,000 samples daily with its products, impacting approximately 4 million patients annually. Radiometer's core offerings include automated blood gas testing systems, integrated IT platforms for regulatory compliance and data management, and consumable supplies for acute care diagnostics. The company serves hospital networks, emergency departments, and intensive care units seeking standardized, automated diagnostic workflows. Radiometer operates as part of Danaher Corporation and maintains a customer portal using Microsoft Azure AD authentication, indicating enterprise-level software and data security infrastructure. The company's mission emphasizes streamlining diagnostic workflows to enable clinicians to focus on patient care in critical settings.

Medinova is a medical device manufacturer specializing in premium stethoscopes and diagnostic auscultation instruments. The company designs and produces acoustically engineered stethoscopes for healthcare professionals across multiple specialties, including cardiology, pulmonology, and pediatrics. All Medinova stethoscopes feature aircraft-grade stainless steel construction, latex-free tubing, and advanced acoustic chambers engineered to isolate ambient noise and enhance body sound clarity across high and low frequencies. The product line emphasizes ergonomic design for extended clinical use, with lightweight tubing and soft ear seals to reduce practitioner fatigue during long shifts. Medinova serves a global market, with products distributed across 50+ countries and trusted by medical students, clinicians, and specialists. The company maintains an in-house R&D capability focused on continuous acoustic innovation and clinical validation. Each model undergoes acoustic testing and clinical validation before market release. Manufacturing utilizes precision engineering techniques to ensure consistent sound quality and durability. The company operates a B2C and B2B distribution model through its website and professional healthcare channels.

Bluedrop RPM is a remote patient monitoring (RPM) company specializing in diabetic foot ulcer (DFU) prevention and early detection. The company develops at-home foot scanning and monitoring solutions designed for patients with diabetes who are at high risk for peripheral neuropathy-related foot complications. Bluedrop's primary offering is OneStep, a smart-scale foot scanner that captures high-resolution images and thermal data in under 30 seconds per day. The device pairs with EveryStep, a cloud-based monitoring service that analyzes scan data, identifies risk indicators, and communicates findings directly to patients and their healthcare providers when clinical escalation is warranted. The platform emphasizes ease of use and consistent patient engagement to enable early-stage DFU detection, which significantly reduces treatment costs and clinical severity. Bluedrop reports an average patient compliance of approximately 4 scans per week, with detected ulcers graded at Stage 1 upon clinical escalation. The company serves both individual patients seeking convenient at-home foot health management and healthcare providers seeking to reduce preventable complications in their highest-risk diabetic populations. Bluedrop operates with offices in Houston, TX and Galway, Ireland, positioning the company for both North American and European markets.

Neuroptek is a Canadian-based medical device company specializing in portable, smartphone-integrated eye-tracking and vision testing technology. The company's primary offering is EyeMirage™, a dual-lens optical device paired with a mobile application that enables comprehensive vision assessment and eye movement analysis using standard smartphones. The EyeMirage™ system performs objective measurements including visual acuity, automated visual field testing, color vision assessment, saccadic eye movement analysis, and convergence testing—clinically relevant for concussion diagnosis and neuro-ophthalmologic evaluation. The device accommodates two smartphones simultaneously (one per eye) with custom cases and synchronized dual-screen presentation capability, allowing precise eye-tracking via front-facing camera capture. The companion mobile app (iOS and Android) integrates test administration, personalized health record storage, appointment scheduling, and result documentation. Key clinical applications include sports medicine concussion evaluation, traumatic brain injury assessment, and general neuro-ophthalmologic diagnostics in field, clinic, and home settings. The platform targets team physicians, sports medicine professionals, eye care providers, and institutional settings seeking portable, objective eye-tracking diagnostics. Leadership includes Dr. Behzad Mansouri (CEO, neuro-ophthalmologist and neuroscientist) and Dr. Neda Anssari (CFO, neurologist and concussion specialist), both co-inventors. The company has published extensively in peer-reviewed literature on eye-tracking biomarkers for traumatic brain injury. Note: EyeMirage™ is in investigational status and not yet licensed for commercial sale; pre-order options are announced as forthcoming.

LCR Hallcrest, LLC (trading as Thermographics) is a US-based manufacturer of thermochromic and photochromic specialty inks, dyes, paints, and consumer products that change color in response to temperature and UV light exposure. The company operates an FDA-registered, ISO 13485-certified facility in Glenview, Illinois, manufacturing made-in-USA products. Primary product lines include Feverscan® forehead thermometers for fever detection in clinical and consumer settings, thermochromic and photochromic specialty inks for industrial and educational applications, and consumer items such as aquarium thermometers, battery testers, and propane tank gauges. Thermochromic liquid crystals are used in flow visualization and heat transfer research. The company offers thermochromic test kits, educational materials, and custom color-change promotional products. Products leverage liquid crystal technology and environmental-responsive inks for temperature monitoring, safety applications (vehicle heat alerts, hot water gauges, baby bath thermometers, choking hazard testers), and energy conservation programs. The company serves healthcare facilities, research institutions, educational markets, and consumer segments globally. Manufacturing capabilities include screen printing, ink formulation, and product assembly. All products comply with relevant safety and regulatory standards for medical and consumer use.